Page 370 - Read Online

Page 10 of 14 Pereira et al. J Cancer Metastasis Treat 2018;4:30 I http://dx.doi.org/10.20517/2394-4722.2018.13

DECLARATIONS
Authors’ contributions
Searched bibliographic references data: Pereira NP, Corrêa JR
Edited partial scientific text: Pereira NP, Corrêa JR
Reviewed scientific text: Corrêa JR

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Both authors declare no conflicts of interest in association with this study.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2018.

REFERENCES
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018;68:7-30.
2. Hidalgo M. Pancreatic cancer. N Engl J Med 2010;362:1605-17.
3. Goel G, Sun W. Novel approaches in the management of pancreatic ductal adenocarcinoma: potential promises for the future. J Hematol
Oncol 2015;8:44.
4. Karanikas M, Esempidis A, Chasan ZT, Deftereou T, Antonopoulou M, Bozali F, Amarantidis K, Man YG. Pancreatic cancer from
molecular pathways to treatment opinion. J Cancer 2016;7:1328-39.
5. Soo RA, Yong WP, Innocenti F. Systemic therapies for pancreatic cancer-the role of pharmacogenetics. Curr Drug Targets 2012;13:811-28.
6. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality
worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
7. Bosetti C, Rosato V, Li D, Silverman D, Petersen GM, Bracci PM, Neale RE, Muscat J, Anderson K, Gallinger S, Olson SH, Miller AB,
Bas Bueno-de-Mesquita H, Scelo G, Janout V, Holcatova I, Lagiou P, Serraino D, Lucenteforte E, Fabianova E, Ghadirian P, Baghurst
PA, Zatonski W, Foretova L, Fontham E, Bamlet WR, Holly EA, Negri E, Hassan M, Prizment A, Cotterchio M, Cleary S, Kurtz RC,
Maisonneuve P, Trichopoulos D, Polesel J, Duell EJ, Boffetta P, La Vecchia C. Diabetes, antidiabetic medications, and pancreatic cancer
risk: an analysis from the International Pancreatic Cancer Case-Control Consortium. Ann Oncol 2014;25:2065-72.
8. Sah RP, Nagpal SJ, Mukhopadhyay D, Chari ST. New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev
Gastroenterol Hepatol 2013;10:423-33.
9. Hamilton SR, Aanltonen LA. World Health Organization Classification of Tumours. Pathology and genetics of tumours of the digestive
system. IARC Press 2000.
10. Raimondi S, Lowenfels AB, Morselli-Labate AM, Maisonneuve P, Pezzilli R. Pancreatic cancer in chronic pancreatitis; aetiology,
incidence, and early detection. Best Pract Res Clin Gastroenterol 2010;24:349-58.
11. Hruban RH, Canto MI, Goggins M, Schulick R, Klein AP. Update on familial pancreatic cancer. Adv Surg 2010;44:293-311.
12. Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, Hruban RH. Recent progress in pancreatic cancer. CA
Cancer J Clin 2013;63:318-48.
13. Iodice S, Gandini S, Maisonneuve P, Lowenfels AB. Tobacco and the risk of pancreatic cancer: a review and meta-analysis.
Langenbecks Arch Surg 2008;393:535-45.
14. Chiorean EG, Coveler AL. Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies. Drug Des Devel Ther
2015;9:3529-45.
15. Lee SY, Sissoko M, Hartshorn KL. Update on the management of pancreatic cancer in older adults. Curr Oncol Rep 2016;18:60.